-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the pharmaceutical industry, with changes in the pharmaceutical environment, major pharmaceutical companies are busy adjusting their businesses to better respond to market opportunities and challenges
.
In the process of business adjustment, there are also major changes in the senior management
.
It was reported on January 28 that within one day, the executives of two pharmaceutical companies, including China Resources Sanjiu and Buchang Pharmaceutical, had changed, and the positions that left were all directors
.
China Resources Sanjiu announced that the board of directors of the company received the resignation report submitted by directors Mr.
Han Yuewei and Mr.
Wei Xing on February 18, 2022.
Due to job changes, Han Yuewei proposed to resign as a director of the eighth board of directors of the company, and Wei Xing proposed to resign from the company.
Director of the Eighth Session of the Board of Directors and member of the Remuneration and Appraisal Committee of the Board of Directors
.
No longer hold positions in the company after resignation
.
The board of directors of Buchang Pharmaceutical also received a written resignation report submitted by the company's director and vice president Li Weijun on February 18, 2022
.
According to the report, Li Weijun applied to resign as the company's director, vice president and member of the compensation and appraisal committee of the board of directors due to personal reasons, and at the same time resigned from all positions held in the company's subsidiaries
.
After his resignation from the above-mentioned positions, he will not hold any positions in the company
.
According to the author's incomplete statistics, including China Resources Sanjiu and Buchang Pharmaceuticals, since 2022, more than 8 directors of pharmaceutical companies have resigned, including China Resources Shuanghe, Sihuan Pharmaceutical, Longxiang Pharmaceutical, Anke Bio, Waltdyne and other pharmaceutical companies
.
For example, on February 14, China Resources Shuanghe announced that due to work arrangements, Han Yuewei applied for his resignation as a director of the company's ninth board of directors and a member of special committees
.
On February 10, Sihuan Pharmaceutical announced that Mr.
Qian Guoshuang applied for his resignation as an independent director and a member of the nomination committee of the ninth board of directors of the company due to personal reasons.
After resigning, he no longer held any positions in the company.
effective when
.
On January 25, Longxiang Pharmaceutical issued an announcement saying that Mr.
Chen Qingping resigned from relevant positions due to personal reasons and would no longer hold other positions in the company after his resignation. .
On January 24, Anke Biotech announced that Mr.
Zheng Weiguo was originally scheduled to serve a term of three years until the term of the seventh board of directors of the company expired.
Now he has applied for resignation as director and vice president of the seventh board of directors of the company due to personal reasons.
Mr.
Zheng Weiguo After resigning, he will no longer hold any position in the company
.
On January 22, Huatda issued an announcement that Mr.
Song Junbo applied for his resignation as an independent director of the company due to personal reasons, and at the same time resigned from relevant positions in various professional committees of the board of directors such as the director of the Nomination Committee of the 10th Board of Directors
.
After his resignation, Mr.
Song Junbo will not hold any position in the company
.
On January 13, Sunshine Guojian announced that Mr.
ZHU ZHENPING resigned from the position of non-independent director/deputy general manager/head of R&D of the fourth board of directors of the company due to job adjustment, and will no longer hold any position in the company after resignation
.
Judging from the reasons for resignation, the resignation of the above-mentioned directors of pharmaceutical companies is mainly related to personal reasons and work arrangements, mainly personal reasons
.
According to the industry, directors are the core of a pharmaceutical company and are mainly responsible for the daily operation and management of the company
.
In the current context of accelerated adjustment and upgrading of the pharmaceutical industry, personnel changes are inevitable, and many directors will have their own higher pursuits.
It is expected that the tide of resignation of pharmaceutical company directors will continue in the future
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
In the process of business adjustment, there are also major changes in the senior management
.
It was reported on January 28 that within one day, the executives of two pharmaceutical companies, including China Resources Sanjiu and Buchang Pharmaceutical, had changed, and the positions that left were all directors
.
China Resources Sanjiu announced that the board of directors of the company received the resignation report submitted by directors Mr.
Han Yuewei and Mr.
Wei Xing on February 18, 2022.
Due to job changes, Han Yuewei proposed to resign as a director of the eighth board of directors of the company, and Wei Xing proposed to resign from the company.
Director of the Eighth Session of the Board of Directors and member of the Remuneration and Appraisal Committee of the Board of Directors
.
No longer hold positions in the company after resignation
.
The board of directors of Buchang Pharmaceutical also received a written resignation report submitted by the company's director and vice president Li Weijun on February 18, 2022
.
According to the report, Li Weijun applied to resign as the company's director, vice president and member of the compensation and appraisal committee of the board of directors due to personal reasons, and at the same time resigned from all positions held in the company's subsidiaries
.
After his resignation from the above-mentioned positions, he will not hold any positions in the company
.
According to the author's incomplete statistics, including China Resources Sanjiu and Buchang Pharmaceuticals, since 2022, more than 8 directors of pharmaceutical companies have resigned, including China Resources Shuanghe, Sihuan Pharmaceutical, Longxiang Pharmaceutical, Anke Bio, Waltdyne and other pharmaceutical companies
.
For example, on February 14, China Resources Shuanghe announced that due to work arrangements, Han Yuewei applied for his resignation as a director of the company's ninth board of directors and a member of special committees
.
On February 10, Sihuan Pharmaceutical announced that Mr.
Qian Guoshuang applied for his resignation as an independent director and a member of the nomination committee of the ninth board of directors of the company due to personal reasons.
After resigning, he no longer held any positions in the company.
effective when
.
On January 25, Longxiang Pharmaceutical issued an announcement saying that Mr.
Chen Qingping resigned from relevant positions due to personal reasons and would no longer hold other positions in the company after his resignation. .
On January 24, Anke Biotech announced that Mr.
Zheng Weiguo was originally scheduled to serve a term of three years until the term of the seventh board of directors of the company expired.
Now he has applied for resignation as director and vice president of the seventh board of directors of the company due to personal reasons.
Mr.
Zheng Weiguo After resigning, he will no longer hold any position in the company
.
On January 22, Huatda issued an announcement that Mr.
Song Junbo applied for his resignation as an independent director of the company due to personal reasons, and at the same time resigned from relevant positions in various professional committees of the board of directors such as the director of the Nomination Committee of the 10th Board of Directors
.
After his resignation, Mr.
Song Junbo will not hold any position in the company
.
On January 13, Sunshine Guojian announced that Mr.
ZHU ZHENPING resigned from the position of non-independent director/deputy general manager/head of R&D of the fourth board of directors of the company due to job adjustment, and will no longer hold any position in the company after resignation
.
Judging from the reasons for resignation, the resignation of the above-mentioned directors of pharmaceutical companies is mainly related to personal reasons and work arrangements, mainly personal reasons
.
According to the industry, directors are the core of a pharmaceutical company and are mainly responsible for the daily operation and management of the company
.
In the current context of accelerated adjustment and upgrading of the pharmaceutical industry, personnel changes are inevitable, and many directors will have their own higher pursuits.
It is expected that the tide of resignation of pharmaceutical company directors will continue in the future
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
